Emmer’s bill guarantees FDA funds for medical technology, innovation amid government subsidizing gaps

U.S. Rep. Tom Emmer (R-MN) on Feb. 26 presented legislation that would ensure government finances kept streaming to the U.S. Food and Drug Administration (FDA) to help certain medical gadget producers amid government subsidizing gaps.

“Patients deserve access to life-saving devices and companies dedicated to providing these innovations should not have their hands tied by the government’s inability to provide adequate funding for its agencies,” Rep. Emmer said on Tuesday.

The Medical Innovation Never Stops Act of 2019, H.R. 1362, would allow the FDA to keep handling new gadget applications and related candidate client expenses amid any postponements in government appointments, as per Rep. Emmer.

“This common-sense fix will allow the FDA to access funds that companies have already agreed to pay for the review process,” said Rep. Emmer.

Such activity under an ordered H.R. 1362, the congressman stated, additionally would guarantee that the audit procedure of these medicinal gadgets could proceed in an auspicious way, as would patient access to new treatments.

Rep. Emmer brought up that his home state of Minnesota is one of the country’s primary bases for medical technology and innovation.

“These companies work every day to provide critical research for life-saving devices,” he said. “Putting the discovery of new breakthrough technologies at risk only hurts patients all around the country.”

H.R. 1362 has been referred for consideration to the U.S. House Energy and Commerce Committee.